Anne B Newman1, John A Dodson2, Timothy S Church3, Thomas W Buford4, Roger A Fielding5, Stephen Kritchevsky6, Daniel Beavers6, Marco Pahor4, Randall S Stafford7, Anita D Szady4, Walter T Ambrosius6, Mary M McDermott8. 1. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. 2. New York University School of Medicine, New York. 3. Department of Preventative Medicine, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge. 4. University of Florida, Gainesville. 5. Tufts University, Boston, Massachusetts. 6. Wake Forest School of Medicine, Winston-Salem, North Carolina. 7. Stanford University, Palo Alto, California. 8. Northwestern University, Chicago, Illinois.
Abstract
IMPORTANCE: Whether sustained physical activity prevents cardiovascular disease (CVD) events in older adults is uncertain. OBJECTIVE: To test the hypothesis that cardiovascular morbidity and mortality would be reduced in participants in a long-term physical activity program. DESIGN, SETTING, AND PARTICIPANTS: The Lifestyle Interventions and Independence for Elders (LIFE) study was a multicenter, randomized trial. Participants were recruited at 8 centers in the United States. We randomized 1635 sedentary men and women aged 70 to 89 years with a Short Physical Performance Battery (SPPB) score of 9 or less but able to walk 400 m. INTERVENTIONS: The physcial activity (PA) intervention was a structured moderate-intensity program, predominantly walking 2 times per week on site for 2.6 years on average. The successful aging intervention consisted of weekly health education sessions for 6 months, then monthly. MAIN OUTCOMES AND MEASURES: Total CVD events, including fatal and nonfatal myocardial infarction, angina, stroke, transient ischemic attack, and peripheral artery disease, were adjudicated by committee, and silent myocardial infarction was assessed by serial electrocardiograms. A limited outcome of myocardial infarction, stroke, and CVD death was also studied. Outcome assessors and adjudicators were blinded to intervention assignment. RESULTS: The 1635 LIFE study participants were predominantly women (67%), with a mean (SD) age of 78.7 (5.2) years; 20% were African-American, 6% were Hispanic or other race or ethnic group, and 74% were non-Latino white. New CVD events occurred in 121 of 818 PA participants (14.8%) and 113 of 817 successful aging participants (13.8%) (HR, 1.10; 95% CI, 0.85-1.42). For the more focused combined outcome of myocardial infarction, stroke, or cardiovascular death, rates were 4.6% in PA and 4.5% in the successful aging group (HR, 1.05; 95% CI, 0.67-1.66). Among frailer participants with an SPPB score less than 8, total CVD rates were 14.2% in PA vs 17.7% in successful aging (HR, 0.76; 95% CI, 0.52-1.10), compared with 15.3% vs 10.5% among those with an SPPB score of 8 or 9 (HR, 1.59; 95% CI, 1.09-2.30) (P for interaction = .006). With the limited end point, the interaction was not significant (P = .59), with an HR of 0.94 (95% CI, 0.50-1.75) for an SPPB score less than 8 and an HR of 1.20 (95% CI, 0.62-2.34) for an SBBP score of 8 or 9. CONCLUSIONS AND RELEVANCE: Among participants in the LIFE Study, an aerobically based, moderately intensive PA program was not associated with reduced cardiovascular events in spite of the intervention's previously documented ability to prevent mobility disability. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00116194.
RCT Entities:
IMPORTANCE: Whether sustained physical activity prevents cardiovascular disease (CVD) events in older adults is uncertain. OBJECTIVE: To test the hypothesis that cardiovascular morbidity and mortality would be reduced in participants in a long-term physical activity program. DESIGN, SETTING, AND PARTICIPANTS: The Lifestyle Interventions and Independence for Elders (LIFE) study was a multicenter, randomized trial. Participants were recruited at 8 centers in the United States. We randomized 1635 sedentary men and women aged 70 to 89 years with a Short Physical Performance Battery (SPPB) score of 9 or less but able to walk 400 m. INTERVENTIONS: The physcial activity (PA) intervention was a structured moderate-intensity program, predominantly walking 2 times per week on site for 2.6 years on average. The successful aging intervention consisted of weekly health education sessions for 6 months, then monthly. MAIN OUTCOMES AND MEASURES: Total CVD events, including fatal and nonfatal myocardial infarction, angina, stroke, transient ischemic attack, and peripheral artery disease, were adjudicated by committee, and silent myocardial infarction was assessed by serial electrocardiograms. A limited outcome of myocardial infarction, stroke, and CVD death was also studied. Outcome assessors and adjudicators were blinded to intervention assignment. RESULTS: The 1635 LIFE study participants were predominantly women (67%), with a mean (SD) age of 78.7 (5.2) years; 20% were African-American, 6% were Hispanic or other race or ethnic group, and 74% were non-Latino white. New CVD events occurred in 121 of 818 PAparticipants (14.8%) and 113 of 817 successful aging participants (13.8%) (HR, 1.10; 95% CI, 0.85-1.42). For the more focused combined outcome of myocardial infarction, stroke, or cardiovascular death, rates were 4.6% in PA and 4.5% in the successful aging group (HR, 1.05; 95% CI, 0.67-1.66). Among frailer participants with an SPPB score less than 8, total CVD rates were 14.2% in PA vs 17.7% in successful aging (HR, 0.76; 95% CI, 0.52-1.10), compared with 15.3% vs 10.5% among those with an SPPB score of 8 or 9 (HR, 1.59; 95% CI, 1.09-2.30) (P for interaction = .006). With the limited end point, the interaction was not significant (P = .59), with an HR of 0.94 (95% CI, 0.50-1.75) for an SPPB score less than 8 and an HR of 1.20 (95% CI, 0.62-2.34) for an SBBP score of 8 or 9. CONCLUSIONS AND RELEVANCE: Among participants in the LIFE Study, an aerobically based, moderately intensive PA program was not associated with reduced cardiovascular events in spite of the intervention's previously documented ability to prevent mobility disability. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00116194.
Authors: Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert Journal: Circulation Date: 2011-11-03 Impact factor: 29.690
Authors: W Jack Rejeski; George A Bray; Shyh-Huei Chen; Jeanne M Clark; Mary Evans; James O Hill; John M Jakicic; Karen C Johnson; Rebecca Neiberg; Edward H Ip Journal: J Gerontol A Biol Sci Med Sci Date: 2014-07-01 Impact factor: 6.053
Authors: J Niebauer; R Hambrecht; T Velich; K Hauer; C Marburger; B Kälberer; C Weiss; E von Hodenberg; G Schlierf; G Schuler; R Zimmermann; W Kübler Journal: Circulation Date: 1997-10-21 Impact factor: 29.690
Authors: Rebecca H Neiberg; Rena R Wing; George A Bray; David M Reboussin; Amy D Rickman; Karen C Johnson; Abbas E Kitabchi; Lucy F Faulconbridge; Dalane W Kitzman; Mark A Espeland Journal: Obesity (Silver Spring) Date: 2012-02-13 Impact factor: 5.002
Authors: Mark A Espeland; Jeffrey A Katula; Julia Rushing; Arthur F Kramer; Janine M Jennings; Kaycee M Sink; Neelesh K Nadkarni; Kieran F Reid; Cynthia M Castro; Timothy Church; Diana R Kerwin; Jeff D Williamson; Richard A Marottoli; Scott Rushing; Michael Marsiske; Stephen R Rapp Journal: Int J Geriatr Psychiatry Date: 2013-04-16 Impact factor: 3.485
Authors: Anthony P Marsh; Laura C Lovato; Nancy W Glynn; Kimberly Kennedy; Cynthia Castro; Kathryn Domanchuk; Erica McDavitt; Ruben Rodate; Michael Marsiske; Joanne McGloin; Erik J Groessl; Marco Pahor; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2013-05-28 Impact factor: 6.053
Authors: Jeff D Williamson; Mark Espeland; Stephen B Kritchevsky; Anne B Newman; Abby C King; Marco Pahor; Jack M Guralnik; Leslie A Pruitt; Michael E Miller Journal: J Gerontol A Biol Sci Med Sci Date: 2009-02-24 Impact factor: 6.053
Authors: Roger A Fielding; W Jack Rejeski; Steven Blair; Tim Church; Mark A Espeland; Thomas M Gill; Jack M Guralnik; Fang-Chi Hsu; Jeffrey Katula; Abby C King; Stephen B Kritchevsky; Mary M McDermott; Michael E Miller; Susan Nayfield; Anne B Newman; Jeff D Williamson; Denise Bonds; Sergei Romashkan; Evan Hadley; Marco Pahor Journal: J Gerontol A Biol Sci Med Sci Date: 2011-08-08 Impact factor: 6.053
Authors: A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni Journal: J Intern Med Date: 2018-11-22 Impact factor: 8.989
Authors: Tess Harris; Elizabeth S Limb; Fay Hosking; Iain Carey; Steve DeWilde; Cheryl Furness; Charlotte Wahlich; Shaleen Ahmad; Sally Kerry; Peter Whincup; Christina Victor; Michael Ussher; Steve Iliffe; Ulf Ekelund; Julia Fox-Rushby; Judith Ibison; Derek G Cook Journal: PLoS Med Date: 2019-06-25 Impact factor: 11.069
Authors: Marco Pahor; Jack M Guralnik; Stephen D Anton; Walter T Ambrosius; Steven N Blair; Timothy S Church; Mark A Espeland; Roger A Fielding; Thomas M Gill; Nancy W Glynn; Erik J Groessl; Abby C King; Stephen B Kritchevsky; Todd M Manini; Mary M McDermott; Michael E Miller; Anne B Newman; Jeff D Williamson Journal: J Am Geriatr Soc Date: 2020-02-27 Impact factor: 5.562
Authors: Shannon K Cochrane; Shyh-Huei Chen; Jodi D Fitzgerald; John A Dodson; Roger A Fielding; Abby C King; Mary M McDermott; Todd M Manini; Anthony P Marsh; Anne B Newman; Marco Pahor; Catrine Tudor-Locke; Walter T Ambrosius; Thomas W Buford Journal: J Am Heart Assoc Date: 2017-12-02 Impact factor: 5.501
Authors: Joshua A Bell; Mark Hamer; Rebecca C Richmond; Nicholas J Timpson; David Carslake; George Davey Smith Journal: PLoS Med Date: 2018-09-11 Impact factor: 11.069